Insights into the mutation-induced HHH syndrome from modeling human mitochondrial ornithine transporter-1.
about
Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptorsInsights from molecular dynamics simulations: structural basis for the V567D mutation-induced instability of zebrafish alpha-dystroglycan and comparison with the murine modeliNR-Drug: predicting the interaction of drugs with nuclear receptors in cellular networking.Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics.Heterologous Expression in Yeast of Human Ornithine Carriers ORNT1 and ORNT2 and of ORNT1 Alleles Implicated in HHH Syndrome in Humans.Conformational instability of human prion protein upon residue modification: a molecular dynamics simulation study.Ornithine In Vivo Administration Disrupts Redox Homeostasis and Decreases Synaptic Na(+), K (+)-ATPase Activity in Cerebellum of Adolescent Rats: Implications for the Pathogenesis of Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome.Small molecular floribundiquinone B derived from medicinal plants inhibits acetylcholinesterase activity.Computational studies on the substrate interactions of influenza A virus PB2 subunit.Bioassay directed isolation and biological evaluation of compounds isolated from Rubus fairholmianus Gard.Molecular dynamics studies on the conformational transitions of adenylate kinase: a computational evidence for the conformational selection mechanism.π-π Stacking mediated drug-drug interactions in human CYP2E1.Modelling the molecular mechanism of protein-protein interactions and their inhibition: CypD-p53 case study.
P2860
Q28484657-08E4CE87-2896-4AA3-8A48-61695FBDE37CQ28541458-617C8954-83B2-4C0E-B9D2-E53DF28097AAQ37684124-8AA29149-A849-43EE-981E-5D124CE94B56Q39771912-AACFA6B4-9399-439F-B352-62C092B74BDBQ40295242-62C9C24D-D053-40B4-8732-A233F872F664Q40488310-1D5675A4-C7C6-4235-8531-6762E0AE2312Q41221054-3D3286ED-771D-4F34-A6A4-10E2F1439125Q41342817-50BAF150-46DB-4838-98A7-9B8B5CD85E17Q41811018-A78725AD-4486-494E-ABE5-80CA392FC00BQ41834802-2841F184-9F99-4477-A650-05010EA03D0AQ42114141-8B516904-E032-4BAC-9C1F-7B807073DFDBQ44774734-4037CD44-7F15-4529-869D-4D2A0AC586E7Q50955211-064B82FE-BE21-4BF0-B88B-DB754CD8EEC0
P2860
Insights into the mutation-induced HHH syndrome from modeling human mitochondrial ornithine transporter-1.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Insights into the mutation-ind ...... drial ornithine transporter-1.
@ast
Insights into the mutation-ind ...... drial ornithine transporter-1.
@en
type
label
Insights into the mutation-ind ...... drial ornithine transporter-1.
@ast
Insights into the mutation-ind ...... drial ornithine transporter-1.
@en
prefLabel
Insights into the mutation-ind ...... drial ornithine transporter-1.
@ast
Insights into the mutation-ind ...... drial ornithine transporter-1.
@en
P2860
P1433
P1476
Insights into the mutation-ind ...... drial ornithine transporter-1.
@en
P2860
P304
P356
10.1371/JOURNAL.PONE.0031048
P407
P577
2012-01-26T00:00:00Z